arrow
J

Jessica R. Kirshner

regeneron pharmaceuticals inc.
H指数:22
被引数:3,517

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CAR T cells based on fully human T cell receptor-mimetic antibodies exhibit potent antitumor activity in vivo

基于全人源T细胞受体模拟抗体的CAR T细胞在体内表现出强大的抗肿瘤活性。

2025-03-260
PRE
REGN10597: A PD-1-targeted, receptor-masked wild type IL-2 with improved therapeutic window for cancer immunotherapy
2023-12-010
PRE
Generation of T-cell-redirecting bispecific antibodies with differentiated profiles of cytokine release and biodistribution by CD3 affinity tuning

通过CD3亲和力调节产生具有细胞因子释放和生物分布的分化特征的T细胞重定向双特异性抗体

2021-07-1364
OAAI
Antibody drug conjugates of cleavable amino-benzoyl-maytansinoids

可裂解的氨基-苯甲酰基-美登素类化合物的抗体药物缀合物

2020-12-012
PREAI
Selection of CD3 affinity allows generation of T-cell redirecting bispecific antibodies with unique pharmacokinetic and biodistribution properties
2020-08-151
PRE
A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies

一类增强CD3-bispecific抗体抗肿瘤活性的共刺激CD28-bispecific抗体

2020-01-0894
OAAI
A Mucin 16 bispecific T cell-engaging antibody for the treatment of ovarian cancer
2019-06-19100
OAAI
Antibody drug conjugates of cleavable amino-alkyl and aryl maytansinoids

可裂解的氨基烷基和芳基类美登素的抗体药物结合物

2018-05-0121
PREAI
Preclinical Activity of the Novel Anti-Prolactin Receptor (PRLR) Antibody-Drug Conjugate REGN2878-DM1 in PRLR-Positive Breast Cancers
2017-07-0423
OAAI
A novel, native-format bispecific antibody triggering T-cell killing of B-cells is robustly active in mouse tumor models and cynomolgus monkeys
2015-12-11195
OAAI